Actions

Extra: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 1: Line 1:
A pan B-cell marker with good specificity for the identification of B-lineage. CD79a is expressed initially in cytoplasm of early B cells before appearing on the membrane at the time heavy chains of immunoglobulin become expressed.   
A pan B-cell marker with good specificity for the identification of B-lineage. CD79a is expressed initially in cytoplasm of early B cells before appearing on the membrane at the time heavy chains of immunoglobulin become expressed.   


normal expression and function
 
normal expression and function
 
CD79a associates with CD79b and the immunoglobulin chains forming the B-cell receptor. These chains mediate intracellular signalling. However the two chains are expressed slightly differently - CD79a is a more lineage-specific marker than CD79b which often has more variable expression. Expression is acquired at a very early stage of B-lymphocyte formation - initially in cytoplasm, then appearing on the membrane of mature cells and persisting until plasma cell differentiation when it is progressively lost.   
CD79a associates with CD79b and the immunoglobulin chains forming the B-cell receptor. These chains mediate intracellular signalling. However the two chains are expressed slightly differently - CD79a is a more lineage-specific marker than CD79b which often has more variable expression. Expression is acquired at a very early stage of B-lymphocyte formation - initially in cytoplasm, then appearing on the membrane of mature cells and persisting until plasma cell differentiation when it is progressively lost.   


diagnostic role 
* reliable marker of b-lymphocyte lineage with relatively low levels of aberrant expression
*CD79a should be considered more specific than CD19 or CD20 although it may rarely be expressed on other cell types.
*in all expression in cytoplasm is acquired at an early stage of b-lineage commitment pro-b differentiation
*expression is on the cell surface at later differentiation as surface heavy chains are acquired.
*in myeloma about half of cases will express this marker strongly with further proportion having weak expression. 


other relevant information  
diagnostic role
CD79a expression is recognised on some aml and t-all cases so caution should be exercised particularly where other features are atypical. like CD19 expression of CD79a is more often associated with aml that has t 8;21 translocation though less common .  
 
*CD79A is a reliable marker of B-lymphocyte lineage with low levels of aberrant expression; it is more specific than CD19 or CD20 although it may rarely be expressed on other cell types.
*in ALL expression of CD79A in cytoplasm is acquired at an early stage of B-lineage commitment while expression is on the cell surface occurs at later differentiation at the time surface heavy chains are acquired.
*in myeloma about half of cases will express CD79A strongly, but a further proportion have weak expression. 
 
 
other relevant information
CD79a expression is recognised on some cases of AML and T-ALL so caution should be exercised if other features are atypical. Like CD19 the expression of CD79a by AML is more often associated with the t(8;21) translocation.  
 
 


----  summary tables  1. expression by acute leukaemias and by haematogones file freq  pro-b all  hi  early pre-b all  hi  pre-b all  hi  early b all  rare  pro-t all  rare  mature-t all  poss  aml  hi  haemato-gones  link flow cytometry key CD79a cytoplasmic together with CD19 and CD22 can be used in to indicate b-lineage in pro-all and remains cytoplasmic until the b-all stage 2. expression by b-lymphoproliferative disorders file hi frame  cll *  hi  pll**  hi  mcl  hi  fl  *  hi  hcl**  hi  hclv  hi  mzl  hi  lpl  freq  pcs
----  summary tables  1. expression by acute leukaemias and by haematogones file freq  pro-b all  hi  early pre-b all  hi  pre-b all  hi  early b all  rare  pro-t all  rare  mature-t all  poss  aml  hi  haemato-gones  link flow cytometry key CD79a cytoplasmic together with CD19 and CD22 can be used in to indicate b-lineage in pro-all and remains cytoplasmic until the b-all stage 2. expression by b-lymphoproliferative disorders file hi frame  cll *  hi  pll**  hi  mcl  hi  fl  *  hi  hcl**  hi  hclv  hi  mzl  hi  lpl  freq  pcs

Revision as of 21:36, 17 May 2023

A pan B-cell marker with good specificity for the identification of B-lineage. CD79a is expressed initially in cytoplasm of early B cells before appearing on the membrane at the time heavy chains of immunoglobulin become expressed.


normal expression and function

CD79a associates with CD79b and the immunoglobulin chains forming the B-cell receptor. These chains mediate intracellular signalling. However the two chains are expressed slightly differently - CD79a is a more lineage-specific marker than CD79b which often has more variable expression. Expression is acquired at a very early stage of B-lymphocyte formation - initially in cytoplasm, then appearing on the membrane of mature cells and persisting until plasma cell differentiation when it is progressively lost.


diagnostic role

  • CD79A is a reliable marker of B-lymphocyte lineage with low levels of aberrant expression; it is more specific than CD19 or CD20 although it may rarely be expressed on other cell types.
  • in ALL expression of CD79A in cytoplasm is acquired at an early stage of B-lineage commitment while expression is on the cell surface occurs at later differentiation at the time surface heavy chains are acquired.
  • in myeloma about half of cases will express CD79A strongly, but a further proportion have weak expression.


other relevant information

CD79a expression is recognised on some cases of AML and T-ALL so caution should be exercised if other features are atypical. Like CD19 the expression of CD79a by AML is more often associated with the t(8;21) translocation.



summary tables 1. expression by acute leukaemias and by haematogones file freq pro-b all hi early pre-b all hi pre-b all hi early b all rare pro-t all rare mature-t all poss aml hi haemato-gones link flow cytometry key CD79a cytoplasmic together with CD19 and CD22 can be used in to indicate b-lineage in pro-all and remains cytoplasmic until the b-all stage 2. expression by b-lymphoproliferative disorders file hi frame cll * hi pll** hi mcl hi fl * hi hcl** hi hclv hi mzl hi lpl freq pcs